Jul 31, 2014 05:07PM Steve Cohen's Point72 Asset Raises Stake in INSMED (INSM) to 5.4%
Jul 31, 2014 12:19PM Valeant Pharma (VRX) price drop a buying opportunity, Bill Ackman tells CNBC

3,380 total articles have been posted to this category.

Sign-up to StreetInsider.com Premium to see all today's market moving Hedge Funds reports.